Actionable news
0
All posts from Actionable news
Actionable news in ACAD: ACADIA Pharmaceuticals Inc.,

ACADIA Pharmaceuticals Inc. (ACAD)

Data provided by Capital IQ, except where noted.
Market Cap (intraday)5:3.64B
Enterprise Value (Apr 30, 2016)3:3.05B
Trailing P/E (ttm, intraday):N/A
Forward P/E (fye Dec 31, 2017)1:N/A
PEG Ratio (5 yr expected)1:-0.30
Price/Sales (ttm):53,757.98
Price/Book (mrq):16.41
Enterprise Value/Revenue (ttm)3:50,065.83
Enterprise Value/EBITDA (ttm)6:-18.63
Income Statement
Revenue (ttm):61.00K
Revenue Per Share (ttm):0.00
Qtrly Revenue Growth (yoy):-64.60%
Gross Profit (ttm):61.00K
EBITDA (ttm)6:-163.96M
Net Income Avl to Common (ttm):-164.44M
Diluted EPS (ttm):-1.63
Qtrly Earnings Growth (yoy):N/A
Balance Sheet
Total Cash (mrq):215.13M
Total Cash Per Share (mrq):2.13
Total Debt (mrq):0.00
Total Debt/Equity (mrq):N/A
Current...

More